NasdaqGM:HRMYPharmaceuticals
Harmony Biosciences Holdings (HRMY) Reports Impressive Earnings Growth
Harmony Biosciences Holdings (HRMY) recently reaffirmed its revenue guidance for the year and reported impressive growth in earnings for both the second quarter and the first half of 2025. Despite these positive updates, which might have typically supported a stronger upward trend, the company's share price remained flat over the last quarter, moving by only 0.36%. The rather subdued share price movement occurred against a backdrop of broader market gains, where major indexes reached record...